Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone mat...
Website: paragon28.com



Growth: Good revenue growth rate 17.3%, there is slowdown compared to average historical growth rates 51.4%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -10.1%. On average the margin is improving steadily. Gross margin is high, +66.4%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 0% of quarters (showing a gain of -$0.11 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -4.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 7.8% higher than minimum and 64.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.1x by EV / Sales multiple , the company can be 10.0% overvalued

Insiders: For the last 3 months insiders bought company shares on $0.3 mln (0.034% of cap.)

Key Financials (Download financials)

Ticker: FNA
Share price, USD:  (-1.9%)8.8
year average price 13.32  


year start price 18.81 2023-05-01

max close price 18.88 2023-05-04

min close price 8.16 2023-10-26

current price 8.80 2024-04-29
Common stocks: 82 087 329

Dividend Yield:  0.0%
Last revenue growth (y/y):  17.3%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  51.4%
Historical growth of EBITDA:  0.0%
EV / Sales: 3.5x
Margin (EBITDA LTM / Revenue): -10.1%
Fundamental value created in LTM:
Market Cap ($m): 722
Net Debt ($m): 35
EV (Enterprise Value): 757
Price to Book: 4.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-01Zacks Investment Research

Paragon 28 (FNA) Expands Syndesmotic Repair Line With New Launch

2024-03-28Zacks Investment Research

Paragon 28, Inc. (FNA) Moves 16.2% Higher: Will This Strength Last?

2024-02-29Seeking Alpha

Paragon 28, Inc. (FNA) Q4 2023 Earnings Call Transcript

2024-02-12Business Wire

Paragon 28 to Present at the CG 2024 Musculoskeletal Conference

2023-11-20Zacks Investment Research

Paragon 28 (FNA) BEAST Cortical Fibers Launch Boosts Biologics

2023-11-16Zacks Investment Research

Paragon 28 (FNA) New Staple System Expands Ankle Device Line

2023-11-11Seeking Alpha

Paragon 28, Inc. (FNA) Q3 2023 Earnings Call Transcript

2023-11-06Zacks Investment Research

Paragon 28, Inc. (FNA) Surges 12.1%: Is This an Indication of Further Gains?

2023-08-06Seeking Alpha

Paragon 28, Inc. (FNA) Q2 2023 Earnings Call Transcript

2023-08-02Zacks Investment Research

Paragon 28, Inc. (FNA) Reports Q2 Loss, Tops Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FNA FNA FNA FNA FNA FNA
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-29 2023-11-08 2023-08-02 2023-05-04 2023-03-02 2022-11-10
acceptedDate 2024-02-29 16:02:47 2023-11-08 16:10:38 2023-08-02 16:08:40 2023-05-04 16:08:07 2023-03-02 16:10:09 2022-11-10 17:26:12
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 61M 53M 51M 52M 52M 46M
costOfRevenue 20M 10M 9M 9M 10M 8M
grossProfit 40M 42M 42M 43M 42M 38M
grossProfitRatio 0.663 0.803 0.826 0.829 0.815 0.815
researchAndDevelopmentExpenses 8M 7M 8M 7M 7M 6M
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 43M 44M 44M 44M 44M 40M
otherExpenses -860 000 2M -467 000 -179 000 -2M 0
operatingExpenses 51M 51M 52M 51M 51M 46M
costAndExpenses 72M 62M 60M 60M 61M 54M
interestIncome 0 1M 803 000 0 0 0
interestExpense 2M 1M 803 000 1M 1M 1M
depreciationAndAmortization 5M 4M -467 000 3M -2M 3M
ebitda -6M -3M -10M -5M -11M -5M
ebitdaratio -0.104 -0.059 -0.193 -0.092 -0.211 -0.117
operatingIncome -11M -9M -9M -8M -9M -8M
operatingIncomeRatio -0.185 -0.170 -0.183 -0.149 -0.176 -0.185
totalOtherIncomeExpensesNet -8M 2M -467 000 -1M -30M -1M
incomeBeforeTax -19M -8M -11M -9M -39M -10M
incomeBeforeTaxRatio -0.321 -0.160 -0.208 -0.175 -0.760 -0.207
incomeTaxExpense 123 000 -108 000 269 000 -71 000 -370 000 201 000
netIncome -20M -8M -11M -9M -39M -10M
netIncomeRatio -0.323 -0.158 -0.214 -0.174 -0.753 -0.211
eps -0.240 -0.100 -0.130 -0.110 -0.500 -0.130
epsdiluted -0.240 -0.100 -0.130 -0.110 -0.500 -0.130
weightedAverageShsOut 83M 83M 83M 81M 78M 77M
weightedAverageShsOutDil 83M 83M 83M 81M 78M 77M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FNA FNA FNA FNA FNA FNA
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-29 2023-11-08 2023-08-02 2023-05-04 2023-03-02 2022-11-10
acceptedDate 2024-02-29 16:02:47 2023-11-08 16:10:38 2023-08-02 16:08:40 2023-05-04 16:08:07 2023-03-02 16:10:09 2022-11-10 17:26:12
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 76M 35M 57M 86M 38M 56M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 76M 35M 57M 86M 38M 56M
netReceivables 38M 35M 35M 38M 38M 37M
inventory 98M 94M 85M 69M 61M 55M
otherCurrentAssets 4M 5M 3M 4M 5M 2M
totalCurrentAssets 216M 169M 180M 197M 142M 150M
propertyPlantEquipmentNet 77M 74M 71M 67M 62M 59M
goodwill 25M 25M 25M 25M 25M 27M
intangibleAssets 22M 22M 22M 22M 22M 21M
goodwillAndIntangibleAssets 47M 47M 47M 48M 48M 48M
longTermInvestments -3M 0 0 0 0 0
taxAssets 705 000 132 000 319 000 354 000 148 000 841 000
otherNonCurrentAssets 3M 4M 2M 2M 2M 0
totalNonCurrentAssets 125M 125M 120M 116M 112M 107M
otherAssets 0 0 0 -1000.000 0 0
totalAssets 341M 293M 301M 314M 254M 257M
accountPayables 22M 27M 30M 21M 15M 14M
shortTermDebt 1M 640 000 652 000 690 000 728 000 735 000
taxPayables 243 000 635 000 20 000 208 000 184 000 497 000
deferredRevenue 243 000 25M 20 000 0 148 000 841 000
otherCurrentLiabilities 28M 2M 26M 42M 53M 26M
totalCurrentLiabilities 51M 55M 56M 64M 69M 42M
longTermDebt 110M 42M 42M 42M 42M 42M
deferredRevenueNonCurrent 1M 635 000 635 000 0 342 000 59 000
deferredTaxLiabilitiesNonCurrent 233 000 327 000 620 000 377 000 342 000 59 000
otherNonCurrentLiabilities 635 000 1M 2M 2M 2M 28M
totalNonCurrentLiabilities 112M 45M 45M 45M 45M 44M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 1M 1M 0 0 0 0
totalLiabilities 163M 100M 102M 108M 113M 86M
preferredStock 0 0 0 0 0 0
commonStock 827 000 824 000 824 000 821 000 776 000 769 000
retainedEarnings -116M -96M -88M -77M -68M -29M
accumulatedOtherComprehensiveIncomeLoss 132 000 -1M -415 000 -132 000 -33 000 -1M
othertotalStockholdersEquity 292M 290M 286M 281M 208M 201M
totalStockholdersEquity 178M 194M 199M 205M 141M 171M
totalEquity 178M 194M 199M 205M 141M 171M
totalLiabilitiesAndStockholdersEquity 341M 293M 301M 314M 254M 257M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 341M 293M 301M 314M 254M 257M
totalInvestments -3M 0 0 0 0 0
totalDebt 112M 43M 43M 43M 43M 43M
netDebt 36M 8M -14M -43M 4M -13M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FNA FNA FNA FNA FNA FNA
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-29 2023-11-08 2023-08-02 2023-05-04 2023-03-02 2022-11-10
acceptedDate 2024-02-29 16:02:47 2023-11-08 16:10:38 2023-08-02 16:08:40 2023-05-04 16:08:07 2023-03-02 16:10:09 2022-11-10 17:26:12
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome -20M -8M -11M -9M -39M -10M
depreciationAndAmortization 5M 4M 3M 3M 4M 3M
deferredIncomeTax -23M -108 000 -351 000 0 596 000 -403 000
stockBasedCompensation 2M 4M 4M 3M 3M 3M
changeInWorkingCapital -5M -14M -16M -12M 14M -9M
accountsReceivables -4M 568 000 3M 441 000 -2M -3M
inventory -1M -12M -15M -8M -6M -4M
accountsPayables -6M -2M 9M 6M 944 000 -586 000
otherWorkingCapital 5M -226 000 -12M -9M 21M -820 000
otherNonCashItems 24M 224 000 534 000 473 000 3M 977 000
netCashProvidedByOperatingActivities -16M -14M -19M -14M -13M -12M
investmentsInPropertyPlantAndEquipment -5M -7M -8M -8M -7M -6M
acquisitionsNet 248 000 160 000 412 000 0 19M 0
purchasesOfInvestments 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0
otherInvestingActivites -133 000 -229 000 0 223 000 -18M -814 000
netCashUsedForInvestingActivites -5M -7M -8M -8M -7M -6M
debtRepayment -65M -172 000 -199 000 -197 000 -203 000 -189 000
commonStockIssued -129 000 71 000 4000.000 68M 5M 0
commonStockRepurchased 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 129M -1M -2M 1M -3M 1M
netCashUsedProvidedByFinancingActivities 63M -1M -3M 69M 3M 1M
effectOfForexChangesOnCash -1M 435 000 454 000 -340 000 -2000.000 -239 000
netChangeInCash 41M -22M -29M 47M -18M -17M
cashAtEndOfPeriod 76M 35M 57M 86M 38M 56M
cashAtBeginningOfPeriod 35M 57M 86M 38M 56M 73M
operatingCashFlow -16M -14M -19M -14M -13M -12M
capitalExpenditure -5M -7M -8M -8M -7M -6M
freeCashFlow -22M -21M -27M -22M -21M -18M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-29 ET (fiscal 2023 q4)
2023 q3
2023-11-11 ET (fiscal 2023 q3)
2023 q2
2023-08-06 ET (fiscal 2023 q2)
2023 q1
2023-05-07 ET (fiscal 2023 q1)
2022 q4
2023-03-02 ET (fiscal 2022 q4)
2022 q3
2022-11-13 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-29 21:05 ET
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
2024-02-12 16:36 ET
Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
2024-02-06 21:05 ET
Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
2024-02-01 13:00 ET
Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
2024-01-30 21:43 ET
Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
2024-01-26 13:00 ET
Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures
2024-01-17 13:00 ET
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
2024-01-08 14:00 ET
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
2024-01-05 13:00 ET
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
2023-12-19 21:05 ET
Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-14 21:05 ET
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio
2023-11-14 13:00 ET
Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering
2023-11-13 21:05 ET
Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program
2023-11-07 21:05 ET
Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
2023-11-07 21:05 ET
Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility
2023-11-03 12:00 ET
Paragon 28 to Present at Upcoming Investor Conferences
2023-10-17 20:05 ET
Paragon 28 To Report Third Quarter Financial Results on November 7, 2023
2023-09-11 11:00 ET
Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System
2023-08-28 20:05 ET
Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-02 20:05 ET
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
2023-07-28 12:00 ET
Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
2023-07-12 20:05 ET
Paragon 28 To Report Second Quarter Financial Results on August 2, 2023
2023-05-23 12:00 ET
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
2023-05-04 20:05 ET
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
2023-04-26 20:05 ET
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
2023-04-24 20:05 ET
Paragon 28 Launches Phantom® Metatarsal Shortening System
2023-04-20 20:05 ET
Paragon 28 To Report First Quarter Financial Results on May 4, 2023
2023-03-02 21:05 ET
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
2023-03-01 21:05 ET
Paragon 28 to Present at Upcoming Investor Conferences
2023-02-17 19:00 ET
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
2023-02-16 21:05 ET
Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
2023-01-26 03:47 ET
Paragon 28, Inc. Announces Pricing of Public Offering
2023-01-25 21:20 ET
Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
2023-01-10 11:00 ET
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
2022-11-16 21:05 ET
Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference
2022-11-10 21:02 ET
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
2022-10-27 20:02 ET
Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022
2022-08-25 20:02 ET
Paragon 28 to Present at The Morgan Stanley 20th Annual Global Healthcare Conference
2022-08-03 20:02 ET
Paragon 28 Reports Second Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
2022-07-18 12:00 ET
Paragon 28 to Present at The Canaccord Genuity 42nd Annual Growth Conference
2022-07-18 12:00 ET
Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022
2022-07-13 12:00 ET
Paragon 28 Launches Mobile Medical Education Lab Tour, Expanding Opportunities for Foot and Ankle Surgeon Education
2022-06-09 12:00 ET
Paragon 28 Launches Monkey Rings™ Circular External Fixation System
2022-05-19 12:00 ET
Paragon 28 Launches TenoTac™ 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair
2022-05-17 12:00 ET
Paragon 28 Expands Soft Tissue Portfolio with Grappler™ Suture Anchor System Launch
2022-05-09 20:02 ET
Paragon 28 Reports First Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
2022-04-27 12:00 ET
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair
2022-04-19 12:00 ET
Paragon 28 Launches R3ACT™ Stabilization System for Ankle Injuries
2022-04-18 20:03 ET
Paragon 28 To Report First Quarter 2022 Financial Results on May 9, 2022, and Present at the 2022 Bank of America Healthcare Conference on May 10, 2022
2022-03-28 20:02 ET
Paragon 28 Announces Appointment of Meghan Scanlon to Board of Directors
2022-03-10 13:00 ET
Paragon 28 to Present at Upcoming Canaccord Genuity Musculoskeletal Conference and Needham Healthcare Conference
2022-03-08 21:01 ET
Paragon 28 Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Net Revenue Guidance
2022-02-17 13:00 ET
Paragon 28 to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
2022-01-12 12:00 ET
Paragon 28 Announces Acquisition of Disior
2022-01-10 11:00 ET
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021
2021-12-29 12:00 ET
Paragon 28, Inc. R3ACT™ Stabilization System Cleared by FDA
2021-12-16 12:00 ET
Paragon 28 to Present at 24th Annual Needham Growth Conference
2021-12-13 21:01 ET
Paragon 28’s Patient Specific Titanium Talus Spacer Has Been Approved by the U.S. Food and Drug Administration
2021-12-01 12:00 ET
Paragon 28 Announces Addition of B. Kristine Johnson and Kristina Wright to its Board of Directors
2021-11-22 13:01 ET
 Paragon 28 to Present at Piper Sandler 33rd Annual Healthcare Conference
2021-11-22 13:00 ET
Paragon 28 Reports Third Quarter 2021 Financial Results and Provides 2021 Fourth Quarter Net Revenue Guidance
2021-11-15 21:13 ET
Paragon 28, Inc. Circular External Fixation System Cleared by FDA
2021-11-10 21:05 ET
Paragon 28 To Report Third Quarter 2021 Financial Results on November 22, 2021
2021-10-15 21:52 ET
Paragon 28, Inc. Announces Pricing of Initial Public Offering

SEC forms

Show financial reports only

SEC form 8
2024-04-04 00:00 ET
Paragon 28, Inc. published news for 2024 q1
SEC form 8
2024-04-04 00:00 ET
Paragon 28, Inc. published news for 2024 q1
SEC form 8
2024-04-04 00:00 ET
Paragon 28, Inc. published news for 2024 q1
SEC form 10
2024-02-29 16:02 ET
Paragon 28, Inc. reported for 2023 q4
SEC form 8
2024-02-29 16:02 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 8
2024-02-29 16:02 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 8
2024-02-29 16:02 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 10
2024-02-29 00:00 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Paragon 28, Inc. published news for 2023 q4
SEC form 10
2023-11-08 16:10 ET
Paragon 28, Inc. published news for 2023 q3
SEC form 10
2023-11-08 00:00 ET
Paragon 28, Inc. published news for 2023 q3
SEC form 8
2023-11-07 16:03 ET
Paragon 28, Inc. reported for 2023 q3
SEC form 10
2023-08-02 16:08 ET
Paragon 28, Inc. reported for 2023 q2
SEC form 6
2023-08-02 16:03 ET
Paragon 28, Inc. published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Paragon 28, Inc. published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
Paragon 28, Inc. published news for 2023 q2
SEC form 10
2023-05-04 00:00 ET
Paragon 28, Inc. published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Paragon 28, Inc. published news for 2023 q1
SEC form 6
2023-04-06 16:17 ET
Paragon 28, Inc. published news for 2023 q1
SEC form 6
2023-03-27 17:22 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 10
2023-03-02 16:10 ET
Paragon 28, Inc. reported for 2022 q4
SEC form 6
2023-03-02 16:05 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 10
2023-03-02 00:00 ET
Paragon 28, Inc. reported for 2022 q4
SEC form 8
2023-03-02 00:00 ET
Paragon 28, Inc. reported for 2022 q4
SEC form 6
2023-02-22 17:09 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 6
2023-01-30 16:04 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 6
2023-01-25 16:19 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 8
2023-01-25 00:00 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 6
2023-01-10 06:02 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 8
2023-01-10 00:00 ET
Paragon 28, Inc. published news for 2022 q4
SEC form 6
2022-12-01 08:00 ET
Paragon 28, Inc. published news for 2022 q3
SEC form 10
2022-11-10 17:26 ET
Paragon 28, Inc. reported for 2022 q3
SEC form 6
2022-11-10 16:07 ET
Paragon 28, Inc. published news for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Paragon 28, Inc. reported for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Paragon 28, Inc. reported for 2022 q3
SEC form 6
2022-08-04 17:08 ET
Paragon 28, Inc. published news for 2022 q2
SEC form 6
2022-08-04 08:30 ET
Paragon 28, Inc. published news for 2022 q2
SEC form 10
2022-08-03 16:11 ET
Paragon 28, Inc. reported for 2022 q2
SEC form 6
2022-08-03 16:08 ET
Paragon 28, Inc. published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Paragon 28, Inc. reported for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Paragon 28, Inc. reported for 2022 q2
SEC form 6
2022-05-20 16:06 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 10
2022-05-09 16:07 ET
Paragon 28, Inc. reported for 2022 q1
SEC form 6
2022-05-09 16:01 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Paragon 28, Inc. reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Paragon 28, Inc. reported for 2022 q1
SEC form 6
2022-04-20 18:05 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 6
2022-04-14 16:06 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 6
2022-04-13 17:59 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 6
2022-04-05 17:08 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 6
2022-04-05 16:26 ET
Paragon 28, Inc. published news for 2022 q1
SEC form 6
2022-03-30 16:06 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-03-28 16:06 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-03-17 08:31 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 10
2022-03-08 16:14 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-03-08 16:06 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 8
2022-03-08 00:00 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 10
2022-03-08 00:00 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-01-12 07:40 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-01-10 16:55 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2022-01-10 07:43 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Paragon 28, Inc. published news for 2021 q4
SEC form 6
2021-12-03 16:32 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-12-03 16:31 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 10
2021-11-22 08:16 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-11-22 08:03 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 10
2021-11-22 00:00 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 8
2021-11-22 00:00 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-11-15 16:40 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-19 17:10 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3
SEC form 6
2021-10-14 21:30 ET
Paragon 28, Inc. published news for 2021 q3